Significantly altered phospholipids associated with IDC as compared to benign and control tissue samples (p-value < 0.05 for all the altered phospholipids mentioned below).
| Sr. no. | Lipid name | Confirmed name | FC IDC Vs C | AUC IDC Vs C | FC IDC Vs B | AUC IDC Vs B |
|---|---|---|---|---|---|---|
| 1 | PI 20:3 | LPI 20:3 | 18.49 | 0.894 | 5.73 | 0.837 |
| 2 | PE 44:3 | PE (22:1/22:2) | 7.2 | 0.892 | 2.96 | 0.697 |
| 3 | PE 20:0 | LPE 20:0 | 8.18 | 0.871 | 3.15 | 0.746 |
| 4 | PC 42:8 | PC (20:4/22:4) | 7.75 | 0.8 | 3.02 | 0.708 |
| 5 | PC 34:4 | PC (14:0/20:4) | 9.05 | 0.788 | 4.84 | 0.824 |
| 6 | PI 44:8 | PI (22:4/22:4) | 3.9 | 0.75 | 5.34 | 0.917 |
| 7 | PC 32:1 | PC (16:0/16:1) | 6.73 | 0.749 | 3.95 | 0.783 |
| 8 | PI 18:2 | LPI 18:2 | 5.71 | 0.741 | 3.21 | 0.776 |
| 9 | PC 40:7 | PC (18:2/22:5) | 6.04 | 0.703 | 3.04 | 0.736 |
| 10 | PE 18:1 | LPE 18:1 | 8.13 | 0.679 | 7.6 | 0.774 |
| 11 | LPC 22:4 | LPC 22:4 | 1.74 | 0.652 | 0.79 | 0.871 |